Acumen Pharmaceuticals ABOS
- sabirnetug — Alzheimer's Disease Phase 2
- sabirnetug — Alzheimer's Disease Phase 1
- ACU301 — Alzheimer's Disease Preclinical
- ACU401 — Alzheimer's Disease Preclinical
AβOs (1 companies · 4 programs)
Companies with an active program directed at AβOs.